Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamma Bertelsen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2013
Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: the Danish Endometrial Cancer StudyGitte Ørtoft, Estrid Stæhr Hansen, Kamma Bertelsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2011
Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA)Kamma Bertelsen, Gitte Ortoft, Estrid Stæhr Hansen
Gynecologic Oncology|February 15, 2003
Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II studyNina Keldsen, Hanne Havsteen, Ignace Vergote, et al.
Gynecologic Oncology|July 20, 2010
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicinMansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamideGordon J S Rustin, Petra Timmers, Ann Nelstrop, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2013
Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: the Danish Endometrial Cancer StudyGitte Ørtoft, Estrid Stæhr Hansen, Kamma Bertelsen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2011
Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA)Kamma Bertelsen, Gitte Ortoft, Estrid Stæhr Hansen
Gynecologic Oncology|February 15, 2003
Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II studyNina Keldsen, Hanne Havsteen, Ignace Vergote, et al.
Gynecologic Oncology|July 20, 2010
A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicinMansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamideGordon J S Rustin, Petra Timmers, Ann Nelstrop, et al.
Pageof 1